RE: STADA Pharmaceuticals Launches Web Site On Rheumatoid Arthritis & Rheumatrex Dose Pack

[Guest guest]

I did check out the website and there was no info I could find on JRA.

The only line I saw was one where they said RA can start in childhood,

but the average age of onset was between 25 and 50. Michele

STADA Pharmaceuticals Launches Web Site On Rheumatoid

Arthritis & Rheumatrex Dose Pack

* As a side-note, I still haven't been able to enter this website.

Haven't tried with Internet Explorer but it won't work for me with my

Netscape. If anyone has accessed the site, could you let me know if

there's anything on JRA? Thanks, Georgina *

STADA Pharmaceuticals Launches Web Site On Rheumatoid Arthritis and

Rheumatrex Dose Pack http://biz./prnews/040713/phtu002b_1.html

STADA Pharmaceuticals, Inc. has launched a content-rich, interactive web

site, http://www.rheumatrex.info, for rheumatoid arthritis patients,

caregivers, and health care professionals. The web site provides

comprehensive information about rheumatoid arthritis, tools for

improving patient compliance and supporting treatment, and information

about Rheumatrex® Dose Pack (methotrexate sodium tablets).

" We developed the web site to support patients and physicians in

treating this chronic, potentially debilitating disease, and to

encourage patient compliance, which is a significant problem with

methotrexate, " said Angel Biaggi, Vice President of Marketing at STADA

Pharmaceuticals. " The site is an example of STADA's commitment to

improve arthritis treatment by providing new products and supportive,

patient-friendly services. We intend to expand our product line in

arthritis and other rheumatic diseases and become a valuable resource

for physicians and patients. "

The extensive interactive web site educates visitors about rheumatoid

arthritis. It describes its symptoms, diagnostic procedures, and

available treatments, including drug therapy, diet and exercise, and

answers most commonly asked questions. It serves as a primer for newly

diagnosed patients and a supportive tool for medical professionals. The

site also provides downloadable brochures for patients and providers,

who can share the easy-to- understand information with patients.

Rheumatrex.info enables patients taking Rheumatrex® Dose Pack to

register for the COPE (COmpliance and Patient Empowerment) program.

Registrants can then access a range of interactive tools, including a

scheduler, which enables them to keep track of all their doctor's

appointments and other related appointments, such as lab tests, to

maintain a record of Rheumatrex and other medications taken, and to

record their exercise and diet regimen. Patients can also register to

receive real-time weekly reminders to take their Rheumatrex, delivered

by e-mail or a text message to their mobile phones. " We are truly

delighted to offer patients the real-time, state-of- the-art reminders

to help them adhere to the treatment regimen, " said Mr. Biaggi. The site

also features a health assessment questionnaire to help patients and

their healthcare providers to monitor their progress.

Rheumatrex.info supports healthcare providers with educational materials

to be shared with their patients and with tools to help improve patience

compliance. It also enables them to order samples on line and allows

them to learn about the product and support program enhancements offered

by STADA.

About Rheumatrex®

Rheumatrex® Dose Pack (methotrexate sodium) is a once-weekly

disease-modifying anti-rheumatic drug (DMARD) for moderate and severe

rheumatoid arthritis. Since compliance is a significant issue with

methotrexate, STADA Pharmaceuticals recently relaunched Rheumatrex

(which it acquired from Wyeth) in compliance-friendly dose packs. The

product is accompanied by a comprehensive patient compliance and

education program. As a low-dosage oral methotrexate, Rheumatrex® is

an aggressive treatment for rheumatoid arthritis that decreases

symptoms, such as joint swelling and pain, and improves the long-term

outcome. Methotrexate, the most widely prescribed treatment for this

condition, is often an initial and maintenance treatment, prescribed

alone or in combination with drugs such as nonsteroidal, anti-

inflammatory drugs

(NSAIDs) or corticosteroids. In low dosage, methotrexate is generally

well tolerated, but may cause stomatitis, leukopenia, nausea, abdominal

cramps, malaise, undue fatigue, chills and fever, dizziness and

decreased resistance to infection.

[Guest guest]

Thanks, Michele. Maybe as time goes on they'll include some relevant

information on pediatric use.

Aloha,

Georgina

Tepper, Michele wrote:

> I did check out the website and there was no info I could find on JRA.

> The only line I saw was one where they said RA can start in childhood,

> but the average age of onset was between 25 and 50. Michele

>

> -----Original Message-----

> From: Georgina [mailto:gmckin@...]

> * As a side-note, I still haven't been able to enter this website.

> Haven't tried with Internet Explorer but it won't work for me with my

> Netscape. If anyone has accessed the site, could you let me know if

> there's anything on JRA? Thanks, Georgina *

>

> STADA Pharmaceuticals Launches Web Site On Rheumatoid Arthritis and

> Rheumatrex Dose Pack http://biz./prnews/040713/phtu002b_1.html

>

> STADA Pharmaceuticals, Inc. has launched a content-rich, interactive web

> site, http://www.rheumatrex.info, for rheumatoid arthritis patients,

> caregivers, and health care professionals. The web site provides

> comprehensive information about rheumatoid arthritis, tools for

> improving patient compliance and supporting treatment, and information

> about Rheumatrex® Dose Pack (methotrexate sodium tablets).

>

> " We developed the web site to support patients and physicians in

> treating this chronic, potentially debilitating disease, and to

> encourage patient compliance, which is a significant problem with

> methotrexate, " said Angel Biaggi, Vice President of Marketing at STADA

> Pharmaceuticals. " The site is an example of STADA's commitment to

> improve arthritis treatment by providing new products and supportive,

> patient-friendly services. We intend to expand our product line in

> arthritis and other rheumatic diseases and become a valuable resource

> for physicians and patients. "

>

> The extensive interactive web site educates visitors about rheumatoid

> arthritis. It describes its symptoms, diagnostic procedures, and

> available treatments, including drug therapy, diet and exercise, and

> answers most commonly asked questions. It serves as a primer for newly

> diagnosed patients and a supportive tool for medical professionals. The

> site also provides downloadable brochures for patients and providers,

> who can share the easy-to- understand information with patients.

>

> Rheumatrex.info enables patients taking Rheumatrex® Dose Pack to

> register for the COPE (COmpliance and Patient Empowerment) program.

> Registrants can then access a range of interactive tools, including a

> scheduler, which enables them to keep track of all their doctor's

> appointments and other related appointments, such as lab tests, to

> maintain a record of Rheumatrex and other medications taken, and to

> record their exercise and diet regimen. Patients can also register to

> receive real-time weekly reminders to take their Rheumatrex, delivered

> by e-mail or a text message to their mobile phones. " We are truly

> delighted to offer patients the real-time, state-of- the-art reminders

> to help them adhere to the treatment regimen, " said Mr. Biaggi. The site

> also features a health assessment questionnaire to help patients and

> their healthcare providers to monitor their progress.

>

> Rheumatrex.info supports healthcare providers with educational materials

> to be shared with their patients and with tools to help improve patience

> compliance. It also enables them to order samples on line and allows

> them to learn about the product and support program enhancements offered

> by STADA.

>

> About Rheumatrex®

>

> Rheumatrex® Dose Pack (methotrexate sodium) is a once-weekly

> disease-modifying anti-rheumatic drug (DMARD) for moderate and severe

> rheumatoid arthritis. Since compliance is a significant issue with

> methotrexate, STADA Pharmaceuticals recently relaunched Rheumatrex

> (which it acquired from Wyeth) in compliance-friendly dose packs. The

> product is accompanied by a comprehensive patient compliance and

> education program. As a low-dosage oral methotrexate, Rheumatrex® is

> an aggressive treatment for rheumatoid arthritis that decreases

> symptoms, such as joint swelling and pain, and improves the long-term

> outcome. Methotrexate, the most widely prescribed treatment for this

> condition, is often an initial and maintenance treatment, prescribed

> alone or in combination with drugs such as nonsteroidal, anti-

> inflammatory drugs

> (NSAIDs) or corticosteroids. In low dosage, methotrexate is generally

> well tolerated, but may cause stomatitis, leukopenia, nausea, abdominal

> cramps, malaise, undue fatigue, chills and fever, dizziness and

> decreased resistance to infection.